TGFB1 and gastric cancer: Cao Q. et al. found that miR-381 can directly target TMEM16A, inhibit TGF-β signaling pathway and downregulate EMT, thereby inhibiting the proliferation, metastasis and migration of GC cells (Cao et al., 2017).